Cadila Healthcare gets OAI from USFDA for its Moraiya facility

Image
Press Trust of India New Delhi
Last Updated : Aug 07 2019 | 1:35 PM IST

Drug firm Cadila Healthcare on Wednesday said the US health regulator has classified inspection of the company's Moraiya facility in Gujarat as 'official action indicated' (OAI).

According to the United States Food and Drug Administration (USFDA), OAI means regulatory and/or administrative actions will be recommended.

The company has received a letter from the USFDA classifying the inspection conducted at its Moraiya facility from April 22 to May 3 as OAI, Cadila Healthcare said in a filing to the BSE.

"The company believes that this classification will not have any impact on the current supplies or revenues of this facility," it added.

Cadila Healthcare is in the process of sending further updates of its corrective actions to the USFDA and remains hopeful of a positive outcome, the company said.

Shares of Cadila Healthcare were trading at Rs 225.50 per scrip on the BSE, down 0.44 per cent from its previous close.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 07 2019 | 1:35 PM IST

Next Story